EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Androgenetic alopecia: an international expert view on the aetiopathogenesis, quality of life and current and emerging therapeutic approaches

Bianca Maria Piraccini, Maria Fernanda Gavazzoni Dias, Leonardo Spagnol Abraham, Lidia Rudnicka

European Journal of Dermatology · 2026

DOI: 10.1684/ejd.2026.4999 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Dermatology, 2026. Verfasst von Bianca Maria Piraccini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Private Dermatology Practice, Bologna, Italy. Hauptthemen laut MEDLINE: Alopecia, Quality of Life. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Androgenetic alopecia (AGA) or pattern hair loss is a non-scarring hair condition defined by gradually reduced, miniaturized hair follicles. It is a multifactorial disorder primarily triggered by dysregulation of the hair cycle due to alterations between the crosstalk of numerous cell subpopulations. To provide a focus on existing and novel management options, preceded by a short overview of the current knowledge about AGA. A group of international experts in AGA analysed 85 literature sources about AGA (retrieved from PubMed and Google Scholar and published between 2000 and 2025) and discuss current and novel treatment options. Recent research evidenced that targeting the hair follicle and the surrounding tissue, rather than solely relying on solutions offered by minoxidil, finasteride, or other products, provides a safe and highly beneficial improvement of AGA. The authors underscore the significant scientific value and crucial role of advanced dermocosmetics with proven clinical efficacy in the long-term management of AGA, in addition to pharmacological active ingredients or other treatment options. These innovations offer compelling early intervention strategies, potentially delaying reliance on lifelong pharmaceutical regimens and optimizing the overall patient journey and quality of life. In addition to current treatment options of AGA, novel topical non-pharmacological therapeutic options are available, helping to safely and efficiently treat this multifactorial hair condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlopeciaQuality of LifeHumansMinoxidilFinasteride5-alpha Reductase InhibitorsHair Follicle

Stichwörter der Autor:innen

Androgenetic alopeciaaetiologyphysiopathologyquality of lifetherapeutic approachtreatment

Substanzen

MinoxidilFinasteride5-alpha Reductase Inhibitors

Autor:innen und Institutionen

  • Private Dermatology Practice, Bologna, Italy.
  • Department of Dermatology, Fluminense Federal University, Niterói, Brazil; Department of Dermatology, Azulay Dermatology Institute, Rio de Janeiro, Brazil.
  • Trichology Unit, "Hospital Regional da Asa Norte", Brasilia, Brazil.
  • Department of Dermatology, Medical University of Warsaw, Warsaw, Poland.

Zitieren

APA

Piraccini, B. M., Dias, M. F. G., Abraham, L. S., & Rudnicka, L. (2026). Androgenetic alopecia: an international expert view on the aetiopathogenesis, quality of life and current and emerging therapeutic approaches. European Journal of Dermatology. https://doi.org/10.1684/ejd.2026.4999

Vancouver

Piraccini BM, Dias MFG, Abraham LS, Rudnicka L. Androgenetic alopecia: an international expert view on the aetiopathogenesis, quality of life and current and emerging therapeutic approaches. European Journal of Dermatology. 2026. doi:10.1684/ejd.2026.4999

BibTeX
@article{Piraccini2026,
  author = {Piraccini, Bianca Maria and Dias, Maria Fernanda Gavazzoni and Abraham, Leonardo Spagnol and Rudnicka, Lidia},
  title = {Androgenetic alopecia: an international expert view on the aetiopathogenesis, quality of life and current and emerging therapeutic approaches},
  journal = {European Journal of Dermatology},
  year = {2026},
  doi = {10.1684/ejd.2026.4999}
}
Kostenlos starten →